The Beaver Dam Eye study also reported an association between therapeutic thyroid hormone use and early AMD, while a case-control study of the Age-Related Eye Disease Study Research Group reported an association between thyroxine supplementation and a higher risk of geographic atrophy [27,28]. Here, TG is linked to atrophic macular degeneration.